Millbrook Healthcare has been acquired by Cairngorm Capital Partners LLP
The private shareholders of Millbrook Healthcare have sold the company to Cairngorm Capital Partners LLP.
Millbrook is a well-established nationwide provider of equipment, assessment and home-based services to help people live more independently, at home, for longer. The company supports individuals, along the care pathway through the provision of aids, ranging from walkers and frames through to bespoke wheelchairs and specialist active pressure care mattresses. Headquartered in Southampton, Millbrook has 28 depots across the UK, employs 1,000 people and offers a fully integrated service to public authorities.
Cairngorm Capital provides equity capital, strategic advice and management expertise to ambitious companies. In partnership with the long-established management team, it is keen to take advantage of the expected expansion of community care services in the UK and continue to deliver an industry-leading level of service to its key stakeholders.
Oaklins Smith & Williamson, based in the UK, advised the seller in this transaction. The team worked with the directors and shareholders of Millbrook to deliver a successful sale to a partner with the appropriate strategic and operating experience to take the business through its next phase of growth.
Colin Croll
Chairman, Millbrook Healthcare
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more